Lumexa Imaging Inc. Common Stock
LMRI | NASDAQ
$11.17
-$0.24 (-2.10%)
Nov 2, 2026, 11:22 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 |
|---|---|---|---|---|---|---|
PE Ratio | -29.68 | -21.50 | -37 | -48.74 | -54.47 | -71.23 |
PEG Ratio | -0.50 | 0.21 | -0.05 | n/a | 0.79 | n/a |
PS Ratio | 1.04 | 1.06 | 1.81 | 2.04 | 3.55 | 7.06 |
PB Ratio | 1.76 | 1.38 | 2.38 | 9.17 | n/a | 10.83 |
P/FCF Ratio | 34.01 | 94.81 | -359.72 | 565.45 | 391.19 | 90.09 |
P/OCF Ratio | 16.74 | 25.88 | 92.92 | 66.05 | 154.33 | 69.20 |
OCF/S Ratio | 12.42 | 1.16 | 6.39 | 4.58 | -5.70 | 10.20 |
Debt / Equity Ratio | 1.59 | 1.61 | 1.64 | 7.86 | n/a | 8.10 |
Quick Ratio | 1.44 | 1.40 | 1.27 | 0.92 | n/a | 0.99 |
Current Ratio | 1.44 | 1.40 | 1.27 | 0.92 | n/a | 0.99 |
Asset Turnover | 0.15 | 0.14 | 0.15 | 0.15 | n/a | 0.15 |
Interest Coverage | 0.27 | 0.28 | -0.27 | 0.42 | 0.34 | 0.49 |
Return on Equity | 0.45% | 0.29% | -4.89% | -2.10% | n/a | -15.50% |
Return on Assets | 0.15% | 0.10% | -1.63% | -0.21% | n/a | -1.50% |
Return on Invested Capital | 0.13% | 0.15% | -0.46% | 0.83% | n/a | 1% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 10.90% | 9.84% | 11.10% | 15.33% | 14.94% | 8.70% |
Net Profit Margin | 1.04% | 0.68% | -10.72% | -1.35% | -3.14% | -10.10% |
Pretax Profit Margin | 2.18% | 1.22% | -9.43% | -0.09% | -1.76% | -6.46% |
Operating Profit Margin | 1.66% | 1.79% | -2.79% | 5.01% | 4.11% | 6.15% |
FCF Margin | 8.76% | -0.94% | 4.80% | -0.68% | -6.11% | 7.84% |
EBITDA Margin | 7.22% | 13.25% | 5.66% | 16.89% | 15.65% | 11.67% |
Add to Watchlist
Select watchlists to add or remove LMRI